Jazz Pharmaceuticals plc Uncategorized Contracts & Agreements
62 Contracts & Agreements
- Jazz Pharmaceuticals plc (Filed With SEC on March 1, 2022)
- Amendment No (Filed With SEC on March 1, 2022)
- Transaction Agreement, dated as of February 3, 2021, by and among Jazz Pharmaceuticals UK Holdings Limited, Jazz Pharmaceuticals Public Limited Company and GW Pharmaceuticals PLC (Filed With SEC on February 4, 2021)
- Offer Letter, dated as of May 2, 2020, by and between Jazz Pharmaceuticals, Inc. and Kim Sablich (Filed With SEC on August 4, 2020)
- Offer Letter, dated as of February 23, 2020, by and between Jazz Pharmaceuticals, Inc. and Rene Gal (Filed With SEC on May 5, 2020)
- Equity Award Letter, dated as of December 9, 2019, by and between Jazz Pharmaceuticals UK Limited and Samantha Pearce (Filed With SEC on February 25, 2020)
- Compromise Agreement, dated as of October 5, 2019, by and between Jazz Pharmaceuticals Ireland Limited and Paul Treacy (Filed With SEC on February 25, 2020)
- Contract Manufacturing Agreement, dated as of January 20, 2020, by and between Jazz Pharmaceuticals Ireland Limited and Siegfried AG (Filed With SEC on February 25, 2020)
- Offer Letter, dated as of July 5, 2019 by and between Jazz Pharmaceuticals, Inc. and Neena M. Patil (Filed With SEC on November 5, 2019)
- Letter Agreement, dated as of June 10, 2019, by and between Jazz Pharmaceuticals, Inc. and Suzanne Sawochka Hooper (Filed With SEC on August 6, 2019)
- Offer Letter from Jazz Pharmaceuticals, Inc. to Robert Iannone dated as of April 11, 2019 (Filed With SEC on August 6, 2019)
- Contract Variation Agreement by and between Porton Biopharma Limited and Jazz Pharmaceuticals France SAS, dated as of December 20, 2018 (Filed With SEC on February 26, 2019)
- Offer Letter from Jazz Pharmaceuticals, Inc. to Daniel N. Swisher, Jr (Filed With SEC on February 27, 2018)
- JAZZ PHARMACEUTICALS PLC and COMPUTERSHARE TRUST COMPANY, N.A. Rights Agreement Dated as of April 5, 2017 TABLE OF CONTENTS (Filed With SEC on April 5, 2017)
- [JAZZ PHARMACEUTICALS LETTERHEAD] (Filed With SEC on November 9, 2015)
- DATED 20 MARCH 2015 Jazz Pharmaceuticals PLC- and -Essex Bidco Limited AMENDED AND RESTATED AGREEMENT FOR THE ACQUISITION OF THETOPAZ PORTFOLIO BUSINESS OF JAZZ PHARMACEUTICALS... (Filed With SEC on March 23, 2015)
- SCHEDULE 1 (Filed With SEC on February 24, 2015)
- EUSA Pharma, (Europe) Limited Registered Office: The Magdalen Centre, Oxford Science Park, Oxford OX4 4GA Company Registered in England Registration No: 4555273 Vat Registration... (Filed With SEC on February 24, 2015)
- Page 2March 24, 2014 (Filed With SEC on November 4, 2014)
- TENDEROFFER AGREEMENT by and among JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY JAZZ PHARMACEUTICALS ITALY S.R.L. and GENTIUM S.P.A. Dated as of December 19, 2013 (Filed With SEC on December 20, 2013)
- ______________________________________________________________________________JAZZ PHARMACEUTICALS... (Filed With SEC on February 26, 2013)
- ______________________________________________________________________________JAZZ PHARMACEUTICALS... (Filed With SEC on February 26, 2013)
- DATED 8 MAY 2012 (1) JOHN RONAN AND CASTLE COVE PROPERTY DEVELOPMENTS LIMITED (Filed With SEC on August 7, 2012)
- [JAZZ LETTERHEAD] (Filed With SEC on October 28, 2011)
- JAZZ PHARMACEUTICALS, INC. AMENDED AND RESTATED DIRECTORS DEFERREDCOMPENSATION PLAN APPROVED BY THEBOARD: MAY 1, 2007 AMENDED BY THEBOARD: DECEMBER 16, 2008 AMENDED ANDRESTATED BY... (Filed With SEC on November 5, 2010)
- AMENDMENTAGREEMENT NO. 1 (Filed With SEC on November 23, 2009)
- OCTOBER, 23 2009 ELAN PHARMA INTERNATIONAL LIMITED AND (Filed With SEC on November 6, 2009)
- NOL PRESERVATION LOCK-UP AGREEMENT (Filed With SEC on July 7, 2009)
- Revision to Payment Terms of Plea Agreement, dated as of July 17, 2007, between the U.S. Attorney for the Eastern District of New York and Orphan Medical, Inc. (Filed With SEC on March 26, 2009)
- JAZZ PHARMACEUTICALS, INC. NON-EMPLOYEE DIRECTOR (Filed With SEC on November 14, 2008)
- ANTIZOLĀ® PRODUCT RIGHTS ACQUISITION AGREEMENT (Filed With SEC on August 6, 2008)
- 3,848,289 Units JAZZ PHARMACEUTICALS, INC. (Filed With SEC on July 16, 2008)
- FORM OF JAZZ PHARMACEUTICALS, INC. (Filed With SEC on May 15, 2008)
- JAZZ PHARMACEUTICALS, INC. NON-EMPLOYEE DIRECTOR (Filed With SEC on March 31, 2008)
- JAZZ PHARMACEUTICALS, INC. (Filed With SEC on March 31, 2008)
- JPI COMMERCIAL, LLC (Filed With SEC on March 31, 2008)
- JAZZ PHARMACEUTICALS, INC. RESTRICTEDSTOCK UNIT GRANT NOTICE (2007 EQUITYINCENTIVE PLAN) (Filed With SEC on November 9, 2007)
- JAZZ PHARMACEUTICALS, INC. NON-EMPLOYEE DIRECTOR (Filed With SEC on August 10, 2007)
- ACKNOWLEDGMENT (Filed With SEC on August 10, 2007)
- CORPORATE INTEGRITY AGREEMENT BETWEEN THE (Filed With SEC on July 18, 2007)